Interpace Biosciences Inc (PDII)
Sector • Healthcare Industry • Medical Equipment & Supplies |
Industry • Medical Equipment & Supplies |
Sector • Healthcare |
Extremely demanding quarter for PDII over the fourth quarter of 2022 earnings season
PDII reported fourth quarter of 2022 operating surplus of $2.928 million
Published Mar 28 2023
CSIMarket Team / CSIMarket.com
For the fiscal interval ending December 31 2022 PDII decreased a loss per share of $-0.36 per share compare to $-0.89 a year ago and earnings per share improved from $-3.35 per share from the previous quarter.
The revenue went down sharply by -63.875 % to $3.92 million from $10.85 million in the corresponding quarter a year ago and sequentially Revenue Tumbled by -52.119 % from $8.19 million.
In the fiscal interval ending December 31 2022 Interpace Biosciences Inc reported net deficit of $-1.564 million, instead of deficit of $-3.729 million in the corresponding quarter a year ago.
the Medical Equipment & Supplies company announced deficit of $-21.96 million and revenue of $31.84 million in the financial period 2022.
Net deficit per share has widen to $-5.18 from $-3.61 in the previous financial year, while revenue fell by -22.94 % from $41.31 million a year ago.
Interpace Biosciences Inc is expected to report next financial earnings on April 28, 2023.
The revenue went down sharply by -63.875 % to $3.92 million from $10.85 million in the corresponding quarter a year ago and sequentially Revenue Tumbled by -52.119 % from $8.19 million.
In the fiscal interval ending December 31 2022 Interpace Biosciences Inc reported net deficit of $-1.564 million, instead of deficit of $-3.729 million in the corresponding quarter a year ago.
the Medical Equipment & Supplies company announced deficit of $-21.96 million and revenue of $31.84 million in the financial period 2022.
Net deficit per share has widen to $-5.18 from $-3.61 in the previous financial year, while revenue fell by -22.94 % from $41.31 million a year ago.
Interpace Biosciences Inc is expected to report next financial earnings on April 28, 2023.